Embryonics
Embryonics45About
What does Embryonics do?
Embryonics is developing novel artificial intelligence (AI) solutions to address the plateauing success rates in the In Vitro Fertilization (IVF) market. By taking a holistic approach, the company aims to improve outcomes by analyzing embryo development and providing expert insights.
What is Embryonics's revenue?
StartupHub estimates Embryonics's annual revenue at $1.6M (range $1.2M to $3.3M, 66% confidence), based on comparable companies in the sector.
Where is Embryonics headquartered?
Embryonics is headquartered in Tel Aviv, Israel.
When was Embryonics founded?
Embryonics was founded in 2018.
What industry does Embryonics operate in?
Embryonics operates in Healthcare, Medical Imaging, InVitro Fertilization (IVF), HealthTech, MedTech, Biotech.
How many employees does Embryonics have?
Embryonics has approximately 7 people on record.
What is Embryonics's current status?
Embryonics's current operating status is: Inactive.
Ultimed develops an AI-powered platform to streamline medical imaging analysis and reporting for radiologists.
Antaros Medical provides innovative imaging solutions and insights for clinical drug development in metabolic, fibrotic, and inflammatory diseases.
Developing innovative AI-powered surgical navigation and planning solutions for enhanced surgical outcomes.
An entrant is a company tagged Medical Imaging whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.